Top compounds associated with response to PROX1


Feature Type Standardized
Nominal ANOVA
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.2 2e-09
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.21 1e-08
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.26 2e-08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-08
mRNA austocystin d CTRPv2 pan-cancer AAC 0.2 5e-08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA Topotecan CTRPv2 pan-cancer AAC 0.18 5e-08
Download CSV